• Service: Advisory, Transactions & Restructuring, Joint Venture
  • Industry: Infrastructure, Government and Healthcare, Healthcare, Pharmaceuticals
  • Type: Business and industry issue
  • Date: 3/31/2013

Healthcare & life sciences in China – Towards growing collaboration 

KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation. The sector will also see rising mergers and acquisitions and joint ventures, mainly triggered by a growing middle class, aging population and continued urbanisation.



Get in touch with KPMG China



Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.



China in focus

Sector Studies - These studies feature the industry insights and latest developments of specific sectors in China.